• Welcome to MEDVERSATION®
  • Log InREGISTER
  • SITE HELP
  • MEDVERSATION® is brought to you by Centocor Ortho Biotech Inc.

April 24, 2009

 

FDA Approves SIMPONI™ (golimumab)

The U.S. Food and Drug Administration (FDA) has approved SIMPONI™ (golimumab). For more information, review the Centocor Ortho Biotech Inc. press release.

Please see Full Prescribing Information, including Boxed Warning, and Medication Guide for SIMPONI™.

About MEDVERSATION®
Resources & Tools
Information for You

© Centocor Ortho Biotech Inc. 2008-2010. This site is published by Centocor Ortho Biotech Inc., which is solely responsible for its content. This site is intended for Healthcare Professionals in the USA.

Last Complete Site Update On: July 22, 2010